Erectile dysfunction in primary care

Nurse Practitioner

Volumn 29, Issue 12, 2004, Pages 42-55

  Lewis, Jean H ^a   Rosen, Raymond ^a   Goldstein, Irwin ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PAPAVERINE; PHOSPHODIESTERASE INHIBITOR; PIPERAZINE DERIVATIVE; PROSTAGLANDIN E1; SILDENAFIL; VASODILATOR AGENT;

AFTERCARE; ANAMNESIS; DIFFERENTIAL DIAGNOSIS; EPIDEMIOLOGY; HUMAN; IMPOTENCE; INTERPERSONAL COMMUNICATION; MALE; METHODOLOGY; NURSE PATIENT RELATIONSHIP; NURSE PRACTITIONER; NURSING ASSESSMENT; PATIENT EDUCATION; PATIENT SELECTION; PENIS PROSTHESIS; PHYSICAL EXAMINATION; PRIMARY HEALTH CARE; PSYCHOLOGICAL ASPECT; REVIEW; SEXUAL COUNSELING;

AFTERCARE; ALPROSTADIL; CAUSALITY; COMMUNICATION; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMPOTENCE; MALE; MEDICAL HISTORY TAKING; NURSE PRACTITIONERS; NURSE-PATIENT RELATIONS; NURSING ASSESSMENT; PAPAVERINE; PATIENT EDUCATION; PATIENT SELECTION; PENILE PROSTHESIS; PHOSPHODIESTERASE INHIBITORS; PHYSICAL EXAMINATION; PIPERAZINES; PRIMARY HEALTH CARE; SEX COUNSELING; VASODILATOR AGENTS;

EID: 16644361947     PISSN: 03611817     EISSN: 15388662     Source Type: Journal    
DOI: 10.1097/00006205-200412000-00006     Document Type: Article

References (29)

1. Erectile dysfunction. National Kidney and Urologic Diseases Information Clearinghouse, National Institutes of Health. 2002. [Web site]. Erectile Dysfunction.
2. Marwick C: Survey says patients expect little physician help on sex. JAMA 1999;281(23):2173-4.
3. Baldwin K, et al: Underreporting of erectile dysfunction among men with unrelated urologic conditions (abstract). J Urol 2000; 163(Suppl 4):1080.
4. Rosen R: Sexual dysfunction as an obstacle to compliance with antihypertensive therapy. Blood Pressure 1997; 6(Suppl 1):47-51.
5. Jardin A, et al: Recommendations of the 1st International Consultation on Erectile Dysfunction. In: Jardin A, et al., editors. Erectile Dysfunction. Plymouth, UK: Health Publications Ltd; 2000. p. 711-26.
6. Rosen R, et al: The process of care model for the evaluation and treatment of erectile dysfunction. Newark, NJ: University of Medicine and Dentistry of New Jersey-Center for Continuing Education; 1998.
7. Feldman HA, et al: Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994;151(1):54-61.
8. Sadovsky R, Custis K: How a primary care physician approaches erectile dysfunction. In: Mulcahy J, editor. Male sexual function. Totowa, NJ: Humana Press, Inc.; 2001. p. 57-77.
9. Rosen RC, et al: Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999;11(6):319-26.
10. Derby CA, et al: Modifiable risk factors and erectile dysfunction: can lifestyle changes modify risk? Urology 2000;56(2):302-6.
11. Albaugh J, et al: Health care clinicians in sexual health medicine: focus on erectile dysfunction. Urol Nurs 2002;22(4):217-31; quiz 32.
12. Meuleman EJ: Prevalence of erectile dysfunction: need for treatment? Int J Impot Res 2002;14(Suppl 1):S22-8.
13. Lue TF: Erectile dysfunction. N Engl J Med 2000;342(24):1802-13.
14. Levine LA, Lenting EL: Use of nocturnal penile tumescence and rigidity in the evaluation of male erectile dysfunction. Urol Clin North Am 1995;22 (4):775-88.
15. DeBusk R, et al: Management of sexual dysfunction in patients with cardiovascular disease: recommendations of the Princeton Consensus Panel. Am J Cardiol 2000;86(2):175-81.
16. Fink HA, et al: Sildenafil for male erectile dysfunction: a systematic review and meta-analysis. Arch Intern Med 2002;162(12):1349-60.
17. Vrijhof HJ, Delaere KP: Vacuum constriction devices in erectile dysfunction: acceptance and effectiveness in patients with impotence of organic or mixed aetiology. Br J Urol 1994;74(1):102-5.
18. Turner LA, et al: External vacuum devices in the treatment of erectile dysfunction: a one-year study of sexual and psychosocial impact. J Sex Marital Ther 1991;17(2):81-93.
19. Levine LA, Dimitriou RJ: Vacuum constriction and external erection devices in erectile dysfunction. Urol Clin North Am 2001;28(2):335-41, ix-x.
20. Albaugh J, Lewis JH: Insights into the management of erectile dysfunction: Part I. Urol Nurs 1999; 19(4):241-5; quiz 6-7.
21. Impotence treatments: urethral suppositories (MUSE). Erectile Dysfunction Institute. 2003. [Web site].
22. Linet OI, Ogrinc FG: Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. The Alprostadil Study Group. N Engl J Med 1996; 334 (14):873-7.
23. Shabsigh R, et al: Intracavernous alprostadil alfadex is more efficacious, better tolerated, and preferred over intraurethral alprostadil plus optional actis: a comparative, randomized, crossover, multicenter study. Urology 2000; 55 (1):109-13.
24. Montague DK, Angermeier KW: Penile prosthesis implantation. Urol Clin North Am 2001; 28(2):355-61, x.
25. Govier FE, et al: Mechanical reliability, surgical complications, and patient and partner satisfaction of the modern three-piece inflatable penile prosthesis. Urology 1998; 52(2):282-6.
26. Goldstein I, et al: Safety and efficacy outcome of mentor alpha-1 inflatable penile prosthesis implantation for impotence treatment. J Urol 1997; 157 (3):833-9.
27. Wilson SK, et al: Comparison of mechanical reliability of original and enhanced Mentor Alpha I penile prosthesis. J Urol 1999; 162(3 Pt 1):715-8.
28. Carson CC, et al: Efficacy, safety and patient satisfaction outcomes of the AMS 700CX inflatable penile prosthesis: results of a long-term multicenter study. AMS 700CX Study Group. J Urol 2000; 164 (2):376-80.
29. Impotence treatments: penile implants. Erectile Dysfunction Institute. 2003. [Web site].